In addition, the tumor microenvironment efficiently upregulates the expression of galectin-9 on mast cells, which can suppress CD8+ T cells in antitumor immunity in a galectin-9-dependent manner in TC, suggesting a novel mechanism of tumor immune escape during TC progression. Here, CD8A is linked to neoplasm.